Choose the brand aligned with your industry so we can best serve your needs.
For researchers, scientists, and technical professionals: Your one-stop shop for the complete range of laboratory, production, and safety products and services.
KW 2449 (CAS 1000669-72-6) is a multi-targeted kinase inhibitor with potent activity against FLT3 (IC50 6 6 nM) ABL (14 nM) Aurora kinases (4 nM) and FGFR (48 nM) It inhibits both wild-type and T315I-mutated ABL tyrosine kinase In vitro KW 2449 disrupts proliferation through modulation of distinct signaling pathways it downregulates FLT3/STAT5 phosphorylation and induces G1-phase arrest and apoptosis in FLT3-mutated leukemia cells while promoting G2/M arrest via reduced histone H3 phosphorylation in FLT3 wild-type cells KW 2449 is applied in research investigating kinase-driven leukemias and resistance mechanisms to targeted therapies
Encompass Procurement Services Non-distribution item offered as a customer accommodation; additional freight charges may apply. Learn More
KW 2449 (CAS 1000669-72-6) is a multi-targeted kinase inhibitor with potent activity against FLT3 (IC50 6 6 nM) ABL (14 nM) Aurora kinases (4 nM) and FGFR (48 nM) It inhibits both wild-type and T315I-mutated ABL tyrosine kinase In vitro KW 2449 disrupts proliferation through modulation of distinct signaling pathways it downregulates FLT3/STAT5 phosphorylation and induces G1-phase arrest and apoptosis in FLT3-mutated leukemia cells while promoting G2/M arrest via reduced histone H3 phosphorylation in FLT3 wild-type cells KW 2449 is applied in research investigating kinase-driven leukemias and resistance mechanisms to targeted therapies
Encompass Procurement Services Non-distribution item offered as a customer accommodation; additional freight charges may apply. Learn More
Also available in 2 mg 5 mg 10 mg 50 mg 100 mg 500 mg 1 mL 10 mM (in DMSO) and bulk. Please contact Fisher for quotes. KW-2449 is a multiple-targeted inhibitor mostly for Flt3 (IC50 6.6 nM) modestly effective to Bcr-Abl FGFR1 and Aurora A; little inhibitory on PDGFR(beta) IGF-1R EGFR. purity: 99%
Encompass Procurement Services Non-distribution item offered as a customer accommodation; additional freight charges may apply. Learn More
Small and Specialty Supplier Partner Small and/or specialty supplier based on Federal laws and SBA requirements. Learn More
CAY 10465 is a selective and high-affinity AhR agonist with a Ki of 0.2 nM. It demonstrates no effect on the estrogen receptor (Ki >100000 nM). This compound reduces apolipoprotein A-I (apo A-I) levels in HepG2 cells and inhibits the synthesis of the protein.
Selective and high-affinity AhR agonist
No effect on estrogen receptor
Reduces apolipoprotein A-I levels in HepG2 cells
Inhibits protein synthesis
Encompass Procurement Services Non-distribution item offered as a customer accommodation; additional freight charges may apply. Learn More
Small and Specialty Supplier Partner Small and/or specialty supplier based on Federal laws and SBA requirements. Learn More
KW-2449 is a multi-targeted small-molecule kinase inhibitor active against FLT3, ABL (including ABL T315I), and Aurora kinases. It exhibits low-nanomolar potency and is supplied for laboratory research use.
Multi-targeted kinase inhibitor effective against FLT3, ABL, and Aurora kinases.
Low-nanomolar potency with reported IC50s of 6.6, 14, 4, and 48 nM (FLT3, ABL, ABL T315I, Aurora).
Provided as a 10 mM solution in DMSO (1 mL) or as a solid in multiple milligram sizes.
High purity suitable for research (reported purity 99.9%).
Molecular formula C20H20N4O; molecular weight 332.40 g·mol⁻¹.
For research use only; not for human or veterinary use.
Encompass Procurement Services Non-distribution item offered as a customer accommodation; additional freight charges may apply. Learn More